G3BP1 modulates SPOP to promote prostate tumorigenesis

Speckle-type POZ protein (SPOP), a Cullin 3-based ubiquitin ligase (CUL3(SPOP)), acts as a prostate-specific tumor suppressor. Loss-of-function mutations in SPOP occur in 10% of primary prostate cancer with a high Gleason grade and poor prognosis. However, it is unclear how the ubiquitin ligase acti...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukhopadhyay, Chandrani, Zhou, Pengbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Author’s View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890399/
https://www.ncbi.nlm.nih.gov/pubmed/35252555
http://dx.doi.org/10.1080/23723556.2022.2030171
Descripción
Sumario:Speckle-type POZ protein (SPOP), a Cullin 3-based ubiquitin ligase (CUL3(SPOP)), acts as a prostate-specific tumor suppressor. Loss-of-function mutations in SPOP occur in 10% of primary prostate cancer with a high Gleason grade and poor prognosis. However, it is unclear how the ubiquitin ligase activity of SPOP is controlled and how dysregulation of SPOP contributes to malignant transformation. Here, we identified GTPase Activating Protein (SH3 Domain) Binding Protein 1 (G3BP1) as an interactor and upstream regulator of CUL3(SPOP), and it functions as an inhibitor of CUL3(SPOP) ubiquitin ligase, suggesting a distinctive mode of CUL3(SPOP) inactivation that aggravates prostate cancer.

Ejemplares similares